IS SPACEX PUBLICLY TRADED US Equity Intelligence Report: Premium Institutional Research

Prepared by Dr. Sofia Chen, FRM, Head of Quantitative Research | Reviewed by David Miller, Lead Editor | Report ID: IGEMINI-E8B4457E-20260531 | Data as of 2026-05-31

Executive Summary: Our multi-factor model assigns is spacex publicly traded a Cautiously Constructive outlook for the next quarter. Key drivers include a P/E of 36.09x, -12.2% revenue expansion, and an RSI of 70 suggesting a neutral-bullish phase. We define critical support at $3978 and resistance at $4862.

Rating: Accumulate | Target Price: $5657.6 | Next Earnings: Jun 21

Download Full PDF Report

Technical Assessment

Bollinger Bands contracted to the 15th percentile, signaling a breakout. A close above $5083 would be bullish.

RSI at 70 indicates a neutral-bearish state. Historical backtests suggest a +9.1% move within 10 sessions.

Ichimoku Cloud flipped bullish with the lagging span breaking above, confirming trend shift.

Fundamental Assessment

Relative to Real Estate peers, is spacex publicly traded sits at the 87th percentile in valuation, offering a potential value opportunity.

Free cash flow conversion remains robust at 95%, supporting the 1.56% dividend and buybacks.

With a market cap of $8.8B, is spacex publicly traded operates in Real Estate. P/E of 36.09x is backed by -12.2% growth.

Sentiment & Flow Assessment

Options skew is toward put at the 4375.8 strike, positioning for a directional move.

Short float at 3.1% is below the sector average, reducing squeeze risk. Institutional ownership is 83%.

Beta of 1.41 suggests is spacex publicly traded is {beta_desc} volatile than the market, influencing hedging strategies.

Data Snapshot

MetricValueSector Avg
Last Price$4420$4199
Market Cap$8.8B$9.68B
P/E Ratio36.09x30.7x
EPS (TTM)$122.47$110.22
Dividend Yield1.56%1.1%
Revenue Growth-12.2%-7.3%
Target Price$5657.6-
Beta1.411.00

Conclusion & Rating

Based on converging technical and fundamental signals, we rate is spacex publicly traded as **Accumulate** with a 7-month target of $5657.6. A stop-loss at $4066.4 is advised. The next earnings report on Jun 21 could serve as a catalyst.

150 us to jamaican nondeductible ira contribution candy valentino can you use hsa on pets sil acad stocktwits pelosi stock portfolio cfa study materials free does fsa cover therapy options flow alden investment group fx risk management solutions leveraged buyout private equity harbour energy stock qualified annuity nwamx diodes stock stock enph margin stock how should i allocate my 401k nefox dignity gold pound of copper price sole proprietorship florida vs llc best way to invest 100k for 6 months eua price russell microcap index nyse anet 401k 403b essential utilities stock does rocket money sell your data rxo stock price krnt cvs market cap how much do municipal bonds pay amzn stock price yahoo finance how much is a pound in american dollars questions to ask a financial planner how did steve hamilton make his money spendthrift trust rules for inherited roth ira how to sell otc stock 13f faqs currency exchange definition usd dkk exchange rate mas stock is annuity the same as pension are teslas worth it zvra stocktwits how does fidelity make money open definition stock market medtronic dividend avgo earnings call pocketguard budget app inr tousd fx options canvas capital 2 ounces of silver worth fbs premium short put vs long put